HIF1A and lung cancer: As miR-17-92 targets hypoxia-inducible factor (HIF)-1α in lung cancer cells [51], enhanced miR-17-92 expression in activated T cells may promote the type-1 function of T cells at least partially through down-regulation of HIF-1α.